Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122353) titled 'A randomized controlled exploratory study on the effects of different injection frequencies of teriparatide on bone metabolism in postmenopausal patients with hip fractures' on April 13.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking University First Hospital
Condition:
Postmenopausal osteoporotic hip fracture
Intervention:
Group A:Administer once daily. Teriparatide (20 µg per dose, administered once daily for three consecutive months)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-13
Target Sample Size: Group A:14;Group B:14; ...